Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling

Jinhang Gao, Bo Wei, Mengfei Liu, Petra Hirsova, Tejasav S. Sehrawat, Sheng Cao, Xiao Hu, Fei Xue, Usman Yaqoob, Ningling Kang, Huarui Cui, William C.K. Pomerantz, Enis Kostallari, Vijay H. Shah – 7 November 2020

Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis

Rakhi Maiwall, Samba Siva Rao Pasupuleti, Priyanka Jain, Shiv Kumar Sarin – 6 November 2020 – The relevance of hemodynamic derangements on the incidence of recurrent acute kidney injury (AKI) and chronic kidney disease (CKD) in patients with cirrhosis is largely unknown. Consecutive patients with cirrhosis with a complete record of baseline hemodynamics were followed for identifying risk factors for the development of recurrent AKI and CKD by using negative binomial regression and competing risk analysis, respectively.

Hepatology Highlights

Nicholas W. Russo, Robert S. Brown, Gopanandan Parthasarathy, Robert E. Schwartz, Adam Buckholz, Arun B. Jesudian, Enis Kostallari, Cesar Taborda, Joel Wedd, Tejasav S. Sehrawat, Navid Hejazifar, Lauren M. Yang, Daryl T.Y. Lau, Jessica Maiers, Nidhi Jalan‐Sakrikar – 6 November 2020

Hepatology Highlights

Nicholas W. Russo, Robert S. Brown, Gopanandan Parthasarathy, Robert E. Schwartz, Adam Buckholz, Arun B. Jesudian, Enis Kostallari, Cesar Taborda, Joel Wedd, Tejasav S. Sehrawat, Navid Hejazifar, Lauren M. Yang, Daryl T.Y. Lau, Jessica Maiers, Nidhi Jalan‐Sakrikar – 6 November 2020

Subscribe to